milestones

Market Access

Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.

News

Novo Nordisk has claimed a key win in its head-to-head race with Agios to bring an oral PKR activator to the market for sickle cell disease.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.